Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · IEX Real-Time Price · USD
63.58
+1.92 (3.11%)
Mar 27, 2024, 4:30 PM EDT - Market closed

Immunocore Holdings Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
442.63402.47297.36162.1592.46155.48
Cash & Cash Equivalents
442.63402.47297.36162.1592.46155.48
Cash Growth
9.98%35.35%83.39%75.37%-40.53%-
Receivables
52.0933.5819.0112.8512.0517.17
Inventory
4.50.690000
Other Current Assets
29.637.2312.0416.1750.8541.32
Total Current Assets
528.82473.98328.41191.16155.35213.98
Property, Plant & Equipment
42.7438.7839.4247.0369.3426.09
Goodwill and Intangibles
000000.4
Other Long-Term Assets
25.4514.019.398.37.374.26
Total Long-Term Assets
68.1852.7948.8155.3376.7130.75
Total Assets
597526.76377.22246.49232.06244.72
Accounts Payable
17.814.4544.332.1636.8824.44
Deferred Revenue
5.521338.5764.9800
Current Debt
1.391.881.572.5526.390
Other Current Liabilities
114.3271.51-7.96-30.9542.3837.57
Total Current Liabilities
139.02100.8476.4868.75105.6462.01
Long-Term Debt
82.6479.5778.2377.3147.8723.6
Other Long-Term Liabilities
6.497.468.0831.2660.0888.39
Total Long-Term Liabilities
89.1487.0286.31108.56107.96111.99
Total Liabilities
228.16187.86162.78177.31213.6173.99
Total Debt
84.0381.4579.879.8674.2623.6
Debt Growth
3.17%2.07%-0.08%7.54%214.69%-
Retained Earnings
-744.67-689.39-601.74-437.34-348.88-218.97
Comprehensive Income
-36.26-54.670.110.2-0.040.08
Shareholders' Equity
368.84338.9214.4369.1818.4670.73
Net Cash / Debt
358.59321.02217.5682.2918.2131.88
Net Cash / Debt Growth
11.70%47.55%164.40%352.15%-86.20%-
Net Cash Per Share
7.337.025.12---
Working Capital
389.8373.14251.93122.4249.71151.97
Book Value Per Share
7.547.415.051.700.45-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).